MedTrace Logo

Task-oriented Training for Stroke: Impact on Function Mobility

NCT01322607 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2016-04-06

Study results available
· View outcomes & findings →

Summary

Residual neurological deficits from stroke lead to gait inefficiencies, resulting in an extremely high energy cost of movement and contributing to overall disability and lower quality of life. Therefore, interventions targeting movement economy should be developed for those in the chronic phase of stroke recovery. This study is designed to compare the effect of two distinctly different exercise paradigms (a higher-intensity treadmill training program and a lower-intensity group exercise program) on economy of movement during over-ground walking and activities of daily living, as well as the extent to which gains in muscular strength, muscular endurance, and balance predict changes in movement economy.

Conditions

  • Cerebrovascular Accident
  • Stroke

Interventions

BEHAVIORAL

High-intensity Treadmill Exercise

High-intensity treadmill walking program

BEHAVIORAL

Low-intensity Lifestyle Intervention

A low-intensity lifestyle intervention targeted towards group exercises incorporating balance, coordination, and strength.

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Alyssa D Stookey, PhD MS · Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2014-01-31
Completion
2015-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01322607 on ClinicalTrials.gov